Market Place
Sourcing Support
Gemvax Announces Phase 2A Results For Progressive Supranuclear Palsy
29 Oct 2024 //
PR NEWSWIRE
GemVax`s highly promising Phase II Alzheimer`s disease clinical trial results
30 Mar 2021 //
PRNEWSWIRE
Complix and VIB Publish Pioneering Study on Cell-Penetrating Alphabodies
30 Mar 2021 //
PRNEWSWIRE
GemVax & KAEL reports further positive data from GV1001 Phase II
23 Nov 2020 //
PRNEWSWIRE
GemVax & KAEL reports further positive data from GV1001 Ph II Alzheimer`s trial
23 Nov 2020 //
PRNEWSWIRE
GemVax Announces to apply for expanded access IND for GV1001
06 Oct 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.